Gerard R. Martin

ORCID: 0000-0001-5571-5255
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Congenital Heart Disease Studies
  • Cardiovascular Conditions and Treatments
  • Cardiac Structural Anomalies and Repair
  • Congenital Diaphragmatic Hernia Studies
  • Mechanical Circulatory Support Devices
  • Tracheal and airway disorders
  • Cardiac Valve Diseases and Treatments
  • Coronary Artery Anomalies
  • Cardiac Arrest and Resuscitation
  • Cardiac Arrhythmias and Treatments
  • Ultrasound in Clinical Applications
  • Healthcare Policy and Management
  • Cardiovascular Issues in Pregnancy
  • Cardiac, Anesthesia and Surgical Outcomes
  • Vascular anomalies and interventions
  • Neonatal Respiratory Health Research
  • Cardiovascular and Diving-Related Complications
  • Phonocardiography and Auscultation Techniques
  • Infective Endocarditis Diagnosis and Management
  • Cardiovascular Function and Risk Factors
  • Non-Invasive Vital Sign Monitoring
  • Cardiac Imaging and Diagnostics
  • Heart Failure Treatment and Management
  • Atrial Fibrillation Management and Outcomes
  • Kawasaki Disease and Coronary Complications

George Washington University Hospital
2024

Children's National
2014-2023

George Washington University
2014-2023

Boston Children's Hospital
2012-2022

National Heart Institute
2016-2021

Holy Cross Hospital
1999-2021

Multidisciplinary Digital Publishing Institute (Switzerland)
2019

Royal North Shore Hospital
2019

University of Birmingham
2019

Birmingham Women's Hospital
2016-2019

BackgroundPrevious congenital heart disease estimates came from few data sources, were geographically narrow, and did not evaluate throughout the life course. Completed as part of Global Burden Diseases, Injuries, Risk Factors Study 2017, this study aimed to provide comprehensive mortality, prevalence, disability by age for 195 countries territories 1990 2017.MethodsMortality generated aggregate non-fatal five subcategories (single ventricle single pathway anomalies; severe anomalies...

10.1016/s2352-4642(19)30402-x article EN cc-by The Lancet Child & Adolescent Health 2020-01-21

Although newborn screening for critical congenital heart disease (CCHD) was recommended by the US Health and Human Services Secretary's Advisory Committee on Heritable Disorders in Newborns Children to promote early detection, it deemed Secretary of HHS as not ready adoption pending an implementation plan from agencies.To develop strategies safe, effective, efficient screening.A work group convened with members selected Children, American Academy Pediatrics, College Cardiology Foundation,...

10.1542/peds.2011-1317 article EN PEDIATRICS 2011-10-11

Incorporation of pulse oximetry to the assessment newborn infant can enhance detection critical congenital heart disease (CCHD). Recently, Secretary Health and Human Services (HHS) recommended that screening for CCHD be added uniform panel. The American Academy Pediatrics (AAP) has been a strong advocate early fully supports decision HHS. AAP published strategies implementation screening, which addressed issues such as necessary equipment, personnel, training, also provided specific...

10.1542/peds.2011-3211 article EN PEDIATRICS 2011-12-27

Congenital heart disease (CHD) is the leading cause of morbidity and mortality from birth defects worldwide. We report an overview trends in CHD 204 countries territories over past 30 years associations with age, period, cohort.Cause-specific estimates were derived Global Burden Disease 2019 study. utilised age-period-cohort model to estimate overall annual percentage changes (net drifts), 0 4 65-69 (local period cohort relative risks (period/cohort effects) between 1990 2019. This approach...

10.1016/j.eclinm.2021.101249 article EN cc-by EClinicalMedicine 2022-01-01

We sought to determine the prevalence and natural history of cardiac tumors in patients referred for fetal echocardiography.Cardiac are rare; prevalence, reported from autopsy studies all ages, varies 0.0017% 0.28%. Despite many case reports, unclear.Fourteen thousand echocardiograms recorded over an 8-year period seven centers were available retrospective review. Medical records studied reason referral, family tuberous sclerosis, prenatal postnatal course tumor description type.Cardiac...

10.1016/0735-1097(95)80031-b article EN cc-by-nc-nd Journal of the American College of Cardiology 1995-08-01

Background. Tele-echocardiography has the potential to bring real-time diagnoses neonatal facilities without in-house pediatric cardiologists. Many neonates in rural areas, smaller cities, and community hospitals do not have immediate access sonographers or echocardiogram interpretation by This can result suboptimal quality, delay initiation of medical intervention, unnecessary patient transport, increased expenditures. Telemedicine been used with frequency improve efficiency cardiology care...

10.1542/peds.109.1.e3 article EN PEDIATRICS 2002-01-01

While clinical outcomes in pediatric cardiac disease have improved recent years, marked institutional and individual cardiology practice variability exists. Quality improvement science has demonstrated that reducing process variation leads to more favorable outcomes, safer practices, cost savings, operating efficiency. This report describes the undertaken develop first collaborative quality project of Joint Council on Congenital Heart Disease. The chosen aims reduce mortality improve life...

10.1111/j.1747-0803.2009.00328.x article EN Congenital Heart Disease 2009-09-01

Newborn screening for critical congenital heart defects (CCHD) was added to the US Recommended Uniform Screening Panel in 2011. Within 4 years, 46 states and District of Columbia had adopted it into their newborn program, leading CCHD being nearly universal United States. This rapid adoption occurred while there were still questions about effectiveness recommended protocol barriers follow-up infants with a positive screen. In response, Centers Disease Control Prevention partnered American...

10.1542/peds.2015-4573 article EN PEDIATRICS 2016-04-15

Objectives To determine the exposure to, and evaluate potential toxicity from, plasticlzer, di(2-ethylhexyl)phthalate (DEHP) during extracorporeal membrane oxygenation (ECMO) therapy. Design Protocol 1 consisted of a prospective comparison three ECMO circuit designs in vitro. 2 prospective, comparative clinical study evaluating DEHP plasma concentrations vs. non-ECMO patients with respiratory failure. Setting Neonatal intensive care unit at The Children's National Medical Center, Washington,...

10.1097/00003246-199704000-00023 article EN Critical Care Medicine 1997-04-01

10.1016/s0022-5223(19)36689-9 article EN publisher-specific-oa Journal of Thoracic and Cardiovascular Surgery 1991-04-01
Coming Soon ...